XML 50 R11.htm IDEA: XBRL DOCUMENT v2.4.0.8
Segment and Related Information
 3 Months Ended
Sep. 30, 2014
Segment and Related Information
(6) Segment and Related Information

The Company’s business units have been aggregated into three reportable segments: (i) research, (ii) molecular diagnostics and (iii) pharmaceutical and clinical services. The research segment is focused on the discovery of genes, biomarkers and proteins related to major common diseases and includes corporate services such as finance, human resources, legal, and information technology. The molecular diagnostics segment provides testing that is designed to assess an individual’s risk for developing disease later in life, identify a patient’s likelihood of responding to drug therapy and guide a patient’s dosing to ensure optimal treatment, or assess a patient’s risk of disease progression and disease recurrence. The pharmaceutical and clinical services segment provides testing products and services to the pharmaceutical, biotechnology and medical research industries. The Company evaluates segment performance based on results from operations before interest income and expense and other income and expense.

 

Segment revenue and operating income (loss) were as follows during the periods presented:

 

     Molecular      Pharmaceutical &              
(In thousands)    diagnostics      clinical services     Research     Total  

Three months ended September 30, 2014:

          

Revenue

    $ 164,507         4,330        —        $ 168,837   

Depreciation and amortization

      4,978         449        527        5,954   

Segment operating income (loss)

      45,083         (1,782 )      (17,381 )      25,920   

Three months ended September 30, 2013:

          

Revenue

    $ 192,987         9,480        —        $ 202,467   

Depreciation and amortization

      1,362         500        510        2,372   

Segment operating income (loss)

      97,746         1,838        (16,680 )      82,904   

 

     Three months ended  
     September 30,  
(In thousands)    2014     2013  

Total operating income for reportable segments

    $ 25,920      $ 82,904   

Interest income

      55        1,362   

Other

      (98 )      (439 ) 

Income tax provision

      9,895        28,362   
  

 

 

    

 

 

  

Net income

    $ 15,982      $ 55,465